Results from an early-phase randomized clinical trial of Chinese vaccine candidate Covid-19 CoronaVac show that the formulation appears safe and induces an antibody response in volunteers aged 18 to 59 years. The results, published in The Lancet, add to the number of candidate vaccines tested that have been found safe. …
Read More »China’s Covid Vaccine Appears Safe, Causes Immune Response
